The High Cost of New Cancer Therapies—A Challenge of Inequality for All Countries

This Viewpoint describes the high cost of new cancer therapies, making comparisons to the early years of the AIDS epidemic, when many patients in low-resource countries died because of the initial high cost of HIV medications.